Submission to FDA: Video Ads for Prescription Drugs and Vaccines that use Distracting Images or Music when Risks are Presented
KEI Research Note 2023:1
May 15, 2023
KEI-RN-2023-1-Distracting-Music-Images-in-Pharma-Ads
(Note: Submitted to Regulations.gov in support of Citizen Petition FDA-2020-P-1725, “Request that the FDA amend §202.1 of the Code of Federal Regulations Title 21 on Prescription-Drug Advertisements to include a provision that bans background music from the presentation of the risks section of direct to consumer prescription drug advertising (21 C.F.R. §202.1)”)